Position in VTRS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,139,745
+$442,933 QoQ
Shares Held
197,717
-1.0% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#215
of 1,020 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 30%
Shared 0%
None 70%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CAPTRUST FINANCIAL ADVISORS holds $43,412,538 across 29 Drug Manufacturers - Specialty & Generic names. VTRS ranks #4 (7.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
121,151 | $8,705,910 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
45,360 | $7,644,974 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
9,855 | $5,339,734 | |
| 4 | VTRS |
Viatris Inc
This page
|
197,717 | $3,139,745 | |
| 5 | HLN |
Haleon plc
|
263,202 | $2,455,674 | |
| 6 | HROW |
Harrow, Inc.
|
56,414 | $2,395,902 | |
| 7 | TAK |
Takeda Pharmaceutical Co Ltd
|
143,998 | $2,308,287 | |
| 8 | ALKS |
Alkermes plc.
|
42,278 | $2,215,367 |
All Filings in VTRS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,139,745 | 197,717 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,696,812 | 199,616 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,606,569 | 209,363 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,073,951 | 209,490 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $1,856,547 | 207,900 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $1,470,012 | 168,773 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,052,581 | 164,866 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,762,444 | 151,804 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,889,950 | 177,794 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $2,273,340 | 190,397 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,348,463 | 216,848 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,305,672 | 233,841 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $2,508,842 | 251,387 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $2,407,789 | 250,290 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,766,676 | 158,731 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $1,384,031 | 162,445 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $832,218 | 79,486 | Shares | Sole | 2022-08-23 | |
| 2022-03-31 | $907,609 | 83,420 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $917,712 | 67,828 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $892,877 | 65,895 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $895,611 | 62,674 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $915,509 | 65,534 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,569,156 | 83,733 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||